Moleculin Biotech Inc Live Stock Price Today, Share Analysis and Chart

Name: Moleculin Biotech Inc: Is Infosys Ltd. worth buying?
Item: Moleculin Biotech Inc
Rating: 0.47166675
Author: Trendlyne DVM scores

about

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline ...

0.39 0.00 (0.00%)

89.32% Fall from 52W High

4.7M

XNAS Volume

High vol.+loss this week

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.2 / 100

Technically Bearish

18.7 / 100

No estimates available

Moleculin Biotech Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Moleculin Biotech Inc Live Stock Price Today, Share Analysis and Chart

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline ...

89.32% Fall from 52W High

High vol.+loss this week

SWOT Analysis

Moleculin Biotech Inc Live Price Chart